Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis

The identification of pharmacogenetic factors that increase the susceptibility to clozapine-induced agranulocytosis or granulocytopenia (CIAG) has received increasing interest. The SLCO1B3-SCLO1B7 variant (rs149104283) and single amino acid changes in human leukocyte antigen (HLA) HLA-DQB1 (126Q) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ninomiya, Kohei, Saito, Takeo, Ikeda, Masashi, Iwata, Nakao, Girardin, François R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614368/
https://www.ncbi.nlm.nih.gov/pubmed/36313369
http://dx.doi.org/10.3389/fphar.2022.1016669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614368/
https://www.ncbi.nlm.nih.gov/pubmed/36313369
http://dx.doi.org/10.3389/fphar.2022.1016669

Ejemplares similares